Men's Health Women's Health Senior's Health Antioxidants Sports Nutrition Diet & Weight Loss Vitamins & Minerals Herbs Specialty Supplements Targeted Supplements Spa Products Anti-Aging Basics Body Systems Body Structure Book Store Pet Health My Recommendation My Favorite Articles Our Most Popular Specials Bargain Basement Brands

MSM

Health News Archive 325 - Heart Bypass Surgery
<<back to structure/function index

Heart Attack Patients Undergoing Bypass Surgery Improve with D-Ribose

Performing cardiopulmonary bypass surgery without the use of a heart-lung machine on patients with acute myocardial infarction has gained acceptance in recent years. Research presented at the recent Federation of American Societies for Experimental Biology (FASEB) meeting in San Diego shows that treating patients with D-Ribose prior to off-pump cardiac revascularization can improve post-operative cardiac function.

Dr. David Perkowski, Chief of Cardiothoracic Surgery at Saddleback Hospital in Laguna Hills, California led the study to investigate further the impact of D-Ribose therapy on myocardial metabolism in these patients. The study included 44 patients with ischemic coronary artery disease who underwent "off-pump" coronary revascularization. Of the 44 patients included in the study, twenty patients were provided with no pre-operative metabolic substrates, while 24 consumed oral D-Ribose in the days before surgery. Cardiac function was measured before and after surgery.

The patients treated with D-Ribose showed a 49% greater increase in cardiac indices after surgery. "Those attending the FASEB conference showed considerable interest in these findings, and with good reason," said Dr. Perkowski. "This study shows that ribose can improve the outcome for many patients facing revascularization, and that more patients may qualify for an 'off-pump' procedure."

Source: Federation of American Societies for Experimental Biology (FASEB) meeting, San Diego, April 29, 2005